In the last century, during the seventies, a great amount of work had shown the important role of drugs in primary and secondary prevention of cardiac disease. Advances in the development of new cardiac drugs have had a major impact on clinical practice. At Prof. Henry H. Neufeld’s instigation, from Tel Aviv, Israel, and in response to this new interest and with the aim of promoting worldwide research and development, a new society under the name “International Society for Cardiovascular Pharmacotherapy” was established in autumn 1983.
Constitution of the International Society for Cardiovascular Pharmacotherapy
November 16, 1983
Prof. Henry N. Neufeld as President and Dr. Alexander Battler as a member of the Board of Directors, both from Israel, signed the Constitution of the International Society for Cardiovascular Pharmacotherapy on November 16, 1983 in Zurich, Switzerland.
Read more1st International Symposium
April 1, 1985
Prof. Neufeld had planned the First Symposium of ISCP to take place in Tel Aviv already in some details, but due to insecurity and visa problems of some potential participants in his country, he contacted urgently Prof. Rutishauser, chief of the Cardiology Center of the University Hospital of Geneva, with the question whether the congress could be transferred to Geneva. Prof. Rutishauser enthusiastically agreed and blocked possible dates in the recently adapted Palexpo Center near the airport of Geneva. Mr. Gideon Rivlin and his wife, very much involved in the planning in Tel Aviv, helped with great initiative…
Read morePassing of Prof. Henry N. Neufeld
December 1, 1986
Henry H. Neufeld was born in Lwowek, Poland on March 13, 1923. He received his Doctor of Medicine degree at the University of Vienna in 1948 and completed his 3 years residency in this same town. From 1951 to 1959 he served as a cardiologist at the Chaim Sheba Medical Center in Tel Aviv. After working for two years as a research fellow under E.H. Wood at the May, Henry Neufeld returned to the Chaim Sheba Medical Center to direct the new…
Read moreLaunch of ISCP’s Official Journal
January 1, 1987
The inauguration of the journal underlines ISCP’s commitment to disseminating research and advancements in the field of cardiovascular pharmacotherapy.
Read more2nd International Symposium and the First General Assembly
October 1, 1987
The second congress of ISCP was organized by Prof. Elliot Rapaport and took place in San Francisco in October 1987. It brought clinical cardiovascular pharmacotherapy successfully to the forefront together with a number of important other topics (hypertension, heart failure, arrhythmias, etc.). The first ordinary General Assembly of ISCP took place during the San Francisco symposium, on October 20, 1987. At that time the society counted 113 members, from 29 different countries. A new Executive Board was elected for a period of two years: W. Rutishauser, Geneva, as President, S. Taylor, Leeds, as Vice-President, A. Battler, Tel Aviv, as Scientific Secretary, C. Kawai, Kyoto, E. Rapaport, San Francisco, J. Ross….
Read moreCardiovascular Drugs and Therapy 1989
May 1, 1989
Even though our Society had already been founded in 1983 in Zurich by the late Professor Henry Neufeld (in the presence of Dr. Battler and with Dr. von Albertini as Executive Secretary), due to the untimely death of the founder the Society has only recently found a “regular rhythm.” The first general assembly of ISCP took place on 29 October 1987 in San Francisco, and the second was held recently,…
Read more3rd International Symposium
October 15, 1989
The third cardiovascular pharmacotherapy international symposium took place in the Kyoto International Conference Hall from October 15-19, 1989 in Kyoto, Japan. The scientific program consisted of plenary sessions, symposia and free papers. The following topics were taken up: Thrombolysis: new agents and concepts. Heart failure therapy. Choice of antihypertensive drugs. Newer approaches for management of cardiac arrhythmias. Treatment of cardiomyopathies. Prostaglandins and leucotriens. Lipid-lowering drugs. Atrial natriuretic factor. Drugs and genetic engineering. Adrenergic receptors. Use of cardiovascular drugs in the elderly. New inotropic agents. Cytokines and cardiovascular system. Calcium currents in vascular and myocardial tissue. Drug effects on vascular smooth muscle. Endothel and cardiovascular agents. Drug tolerance and interaction. Cardiac transplantation and its management. Superoxide dismutase and related substances. Prof. C. Kawai and his scientific secretary, Dr. H. Kambara, both from the 3rd Division, Department of Internal Medicine of the Kyoto University Hospital, did an outstanding job by preparation and realization of the large above-mentioned program. At the general opening session the ISCP President, Prof. Rutishauser, congratulates them wholeheartedly. Then he could open with charming assistance a barrel of the Japanese national drink sake and bring a toast…
Read more4th International Symposium
April 22, 1991
The fourth cardiovascular pharmacotherapy symposium took place in Palexpo Geneva, the small metropolis at the end of the lake, from April 21 to 25, 1991, the year of the 700th anniversary of the origin of the Swiss Confederation. The President of the International Society of Cardiovascular Pharmacotherapy and Chairman of the Satellites, Stanley H. Taylor, M.D., Ph.D., England could count on a potent Organizing Committee, consisting of A. Battler, Israel, F. Burkart, Switzerland, P. Dayer, Switzerland, M. Mancini, Italy, M. Vallotton, Switzerland, and a large…
Read more5th International Symposium
August 16, 1993
The fifth International Symposium was held in Minneapolis, Minnesota, on August 16-20, 1993. The chairman of the congress was Prof. Jay N. Cohn. The President of ISCP and Chairman of the Satellites, Stanley H. Taylor, M.D., Ph.D. England, could count on a potent Organizing Committee, consisting of A. Battler, Israel, F. Burkart, Switzerland, P. Dayer, Switzerland, M. Mancini, Italy, M. Vallotton, Switzerland, and a large Advisory Board under my chairmanship. The program committee had planned an optimally structured program with the newest approaches of therapy in hypertension, atherosclerosis, heart failure, ischemic syndromes and cardiac arrhythmias. In addition 9 satellite symposia were organized in cooperation with pharmaceutical companies. While in the first 10 years the symposia of ISCP were biennial and toured around the world in the sequence…
Read moreISCP Symposium on ACE Inhibition
May 19, 1995
Focused event on ACE inhibition in Versailles.
Read more6th Intl Congress
February 26, 1996
Held in Sydney, continuing ISCP’s global congress series.
Read more7th International Symposium
June 1, 1997
Took place in Jerusalem.
Read more8th Intl Congress
March 28, 1999
Amsterdam hosted this congress.
Read more11th International Congress
May 18, 2002
Montreal hosted the congress.
Read more12th International Congress
May 7, 2003
Barcelona was the location for this event.
Read more13th International Conference
October 1, 2004
ISCP’s conference in Hong Kong.
Read more14th International Congress
November 29, 2007
Antalya hosted the congress.
Read more15th International Congress
October 10, 2009
Took place in Beijing.
Read more16th International Congress
December 4, 2011
Held in Vina del Mar, Chile.
Read more17th International Congress
May 4, 2012
Bucharest hosted this congress.
Read more18th International Congress
June 28, 2013
Rome was the venue for the congress.
Read more
22nd Annual Scientific Meeting
August 24, 2017
Barcelona hosted the meeting.
Read more23rd Annual Scientific Meeting
January 1, 2018
Took place in Kyoto.
Read more24th Annual Scientific Meeting
January 1, 2019
Lugano was the venue for the meeting.
Read more25th Annual Scientific Meeting
January 1, 2020
Scheduled to be held in the USA but cancelled due to the strict restrictions around the COVID-19 pandemic.
Read more
28th Annual Scientific Meeting
November 23, 2023
Hosted in Seoul, South Korea, this meeting continued the tradition of annual scientific gatherings, fostering global discourse in cardiovascular pharmacotherapy.
Read more